Approval Year
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
CFR |
21 CFR 640.30
Created by
admin on Mon Mar 31 20:56:46 GMT 2025 , Edited by admin on Mon Mar 31 20:56:46 GMT 2025
|
||
|
CFR |
21 CFR 640.33
Created by
admin on Mon Mar 31 20:56:46 GMT 2025 , Edited by admin on Mon Mar 31 20:56:46 GMT 2025
|
||
|
CFR |
21 CFR 640.32
Created by
admin on Mon Mar 31 20:56:46 GMT 2025 , Edited by admin on Mon Mar 31 20:56:46 GMT 2025
|
||
|
CFR |
21 CFR 640.34
Created by
admin on Mon Mar 31 20:56:46 GMT 2025 , Edited by admin on Mon Mar 31 20:56:46 GMT 2025
|
||
|
CFR |
21 CFR 640.31
Created by
admin on Mon Mar 31 20:56:46 GMT 2025 , Edited by admin on Mon Mar 31 20:56:46 GMT 2025
|
||
|
FDA ORPHAN DRUG |
595317
Created by
admin on Mon Mar 31 20:56:46 GMT 2025 , Edited by admin on Mon Mar 31 20:56:46 GMT 2025
|
||
|
WHO-ATC |
B05AX03
Created by
admin on Mon Mar 31 20:56:46 GMT 2025 , Edited by admin on Mon Mar 31 20:56:46 GMT 2025
|
||
|
WHO-VATC |
QB05AX03
Created by
admin on Mon Mar 31 20:56:46 GMT 2025 , Edited by admin on Mon Mar 31 20:56:46 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
100000151937
Created by
admin on Mon Mar 31 20:56:46 GMT 2025 , Edited by admin on Mon Mar 31 20:56:46 GMT 2025
|
PRIMARY | |||
|
T74K1VTI2X
Created by
admin on Mon Mar 31 20:56:46 GMT 2025 , Edited by admin on Mon Mar 31 20:56:46 GMT 2025
|
PRIMARY | |||
|
SUB126372
Created by
admin on Mon Mar 31 20:56:46 GMT 2025 , Edited by admin on Mon Mar 31 20:56:46 GMT 2025
|
PRIMARY | |||
|
SUB118891
Created by
admin on Mon Mar 31 20:56:46 GMT 2025 , Edited by admin on Mon Mar 31 20:56:46 GMT 2025
|
PRIMARY | |||
|
T74K1VTI2X
Created by
admin on Mon Mar 31 20:56:46 GMT 2025 , Edited by admin on Mon Mar 31 20:56:46 GMT 2025
|
PRIMARY |
ACTIVE MOIETY
